Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (260)
ATS Statement
2002 • 9,250 citations
Updated Clinical Classification of Pulmonary Hypertension
2013 • 4,123 citations
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
2006 • 3,654 citations
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡
2008 • 3,511 citations
Survival in Patients with Primary Pulmonary Hypertension
1991 • 3,369 citations
Guidelines on the diagnosis and management of acute pulmonary embolism
2008 • 2,836 citations
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 • 2,715 citations
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
2008 • 2,656 citations
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
2007 • 2,638 citations
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 • 2,590 citations
Primary Pulmonary Hypertension
1987 • 2,027 citations
Updated Clinical Classification of Pulmonary Hypertension
2009 • 2,006 citations
Clinical classification of pulmonary hypertension
2004 • 1,915 citations
Pulmonary Arterial Hypertension in France
2006 • 1,904 citations
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
1993 • 1,829 citations
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 • 1,770 citations
Inhaled Iloprost for Severe Pulmonary Hypertension
2002 • 1,760 citations
Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients
1999 • 1,752 citations
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 • 1,541 citations
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
2001 • 1,521 citations
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 • 1,521 citations
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
2002 • 1,383 citations
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension
2002 • 1,382 citations
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
2004 • 1,259 citations
Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
2001 • 1,217 citations
Survival in Primary Pulmonary Hypertension
2002 • 1,192 citations
Chronic thromboembolic pulmonary hypertension.
2006 • 1,170 citations
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
2005 • 1,135 citations
Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension
2000 • 1,129 citations
Diagnosis and Assessment of Pulmonary Arterial Hypertension
2009 • 1,120 citations
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
2002 • 1,096 citations
International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
2006 • 1,079 citations
Primary pulmonary hypertension: natural history and the importance of thrombosis.
1984 • 1,077 citations
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
2000 • 1,051 citations
Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
2006 • 1,046 citations
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 • 1,034 citations
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 • 1,033 citations
Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension
2009 • 1,008 citations
Diagnosis and differential assessment of pulmonary arterial hypertension
2004 • 1,000 citations
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
1991 • 983 citations
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
2009 • 969 citations
Doppler echocardiographic index for assessment of global right ventricular function
1996 • 966 citations
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
2005 • 933 citations
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial
2008 • 910 citations
Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
2003 • 890 citations
Chronic thromboembolic pulmonary hypertension
2018 • 885 citations
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
2000 • 881 citations
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
2006 • 828 citations
Molecular pharmacology
1994 • 813 citations
Bosentan Therapy in Patients With Eisenmenger Syndrome
2006 • 811 citations
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
2009 • 788 citations
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
2002 • 788 citations
Chronic Thromboembolic Pulmonary Hypertension
2001 • 780 citations
Diastolic Heart Failure
2004 • 772 citations
An epidemiological study of pulmonary arterial hypertension
2007 • 768 citations
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
2002 • 763 citations
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
2003 • 750 citations
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
2005 • 738 citations
Sitaxsentan Therapy for Pulmonary Arterial Hypertension
2003 • 723 citations
Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia
2001 • 714 citations
Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension
2006 • 702 citations
Pathologic assessment of vasculopathies in pulmonary hypertension
2004 • 697 citations
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
1990 • 688 citations
Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension
1998 • 674 citations
Pulmonary Arterial Hypertension
2006 • 668 citations
Recommendations on the use of exercise testing in clinical practice
2006 • 667 citations
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
2009 • 663 citations
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
2005 • 659 citations
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
1997 • 658 citations
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
2008 • 657 citations
Clinical Correlates and Reference Intervals for Pulmonary Artery Systolic Pressure Among Echocardiographically Normal Subjects
2001 • 654 citations
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial
2002 • 639 citations
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
2004 • 632 citations
Beraprost therapy for pulmonary arterial hypertension
2003 • 627 citations
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
2006 • 622 citations
Survival with first-line bosentan in patients with primary pulmonary hypertension
2005 • 611 citations
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension
2008 • 609 citations
Genetics and Genomics of Pulmonary Arterial Hypertension
2013 • 606 citations
Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension
2001 • 598 citations
Pulmonary Hemodynamics and Perioperative Cardiopulmonary-Related Mortality in Patients With Portopulmonary Hypertension Undergoing Liver Transplantation
2000 • 590 citations
Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?
2008 • 573 citations
Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report—2006
2006 • 569 citations
Assessment of Survival in Patients With Primary Pulmonary Hypertension
2002 • 562 citations
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers
2006 • 562 citations
Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary Hypertension
2007 • 560 citations
Value of a Doppler-Derived Index Combining Systolic and Diastolic Time Intervals in Predicting Outcome in Primary Pulmonary Hypertension
1998 • 560 citations
Primary pulmonary hypertension
1998 • 539 citations
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
2008 • 533 citations
Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease
1999 • 526 citations
Prognosis of Pulmonary Arterial Hypertension*
2004 • 523 citations
Eisenmenger syndrome. Factors relating to deterioration and death
1998 • 522 citations
Long-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart Defects
1999 • 510 citations
Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
2009 • 505 citations
Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension
2007 • 503 citations
The endothelin system in pulmonary arterial hypertension
2004 • 498 citations
Prognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy
1995 • 497 citations
Ambrisentan Therapy for Pulmonary Arterial Hypertension
2005 • 491 citations
Portopulmonary hypertension and hepatopulmonary syndrome
2004 • 488 citations
Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan
2006 • 481 citations
Pulmonary Hemodynamics in Advanced COPD Candidates for Lung Volume Reduction Surgery or Lung Transplantation
2005 • 479 citations
Goal-oriented treatment and combination therapy for pulmonary arterial hypertension
2005 • 472 citations
Pulmonary veno-occlusive disease
2016 • 453 citations
Long-Term Oxygen Therapy Can Reverse the Progression of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
1985 • 448 citations
Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
2007 • 445 citations
Selection and Treatment of Candidates for Heart Transplantation
1995 • 438 citations
Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.
1996 • 435 citations
Hemodynamics and Survival in Patients With Pulmonary Arterial Hypertension Related to Systemic Sclerosis*
2003 • 431 citations
Vasodilator Therapy for Primary Pulmonary Hypertension in Children
1999 • 425 citations
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
2009 • 415 citations
Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group
1992 • 414 citations
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
2006 • 404 citations
Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary Hypertension
2006 • 400 citations
Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis
1999 • 399 citations
Chronic thromboembolic pulmonary hypertension
2004 • 396 citations
Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
2008 • 396 citations
Risk factors for chronic thromboembolic pulmonary hypertension
2008 • 393 citations
Interventricular Mechanical Asynchrony in Pulmonary Arterial Hypertension
2008 • 388 citations
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007 • 387 citations
Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension
2003 • 381 citations
Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis
2004 • 376 citations
Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease
2006 • 373 citations
The Short-term Effects of Digoxin in Patients With Right Ventricular Dysfunction From Pulmonary Hypertension
1998 • 372 citations
Immunosuppressive therapy in lupus‐ and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty‐three cases
2008 • 366 citations
Portopulmonary hypertension: Results from a 10-year screening algorithm
2006 • 366 citations
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
2003 • 360 citations
Pulmonary vascular disorders in portal hypertension
1998 • 360 citations
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension
1998 • 355 citations
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
2005 • 354 citations
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
2003 • 352 citations
Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry
2006 • 346 citations
Genetics and Genomics of Pulmonary Arterial Hypertension
2009 • 336 citations
Expert consensus document on management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology
2003 • 333 citations
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
2007 • 331 citations
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
2006 • 329 citations
Prognostic Factors for Survival in Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension
2003 • 318 citations
Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
1992 • 318 citations
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension
2003 • 309 citations
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.
1997 • 303 citations
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
2006 • 299 citations
Results of European post-marketing surveillance of bosentan in pulmonary hypertension
2007 • 297 citations
Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension
2006 • 297 citations
Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension
2003 • 294 citations
Severe Pulmonary Hypertension during Pregnancy
2005 • 293 citations
Pulmonary Veno-occlusive Disease
2000 • 292 citations
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
2006 • 291 citations
Safety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension
2006 • 290 citations
Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
1999 • 288 citations
Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation
2008 • 288 citations
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension
2004 • 285 citations
Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure
2005 • 284 citations
Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension
2001 • 282 citations
Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension
2004 • 277 citations
Pulmonary veno-occlusive disease
2008 • 274 citations
Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study
2005 • 274 citations
Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
1996 • 269 citations
Development and Pathology of Pulmonary Hypertension
2009 • 265 citations
Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension
2005 • 263 citations
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
2006 • 262 citations
Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Lung and Heart–Lung Transplantation Report—2006
2006 • 260 citations
Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension
2004 • 260 citations
Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
2004 • 257 citations
Pulmonary Hypertension: CT of the Chest in Pulmonary Venoocclusive Disease
2004 • 256 citations
Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension.
1989 • 250 citations
Beneficial Effect of Oral Sildenafil Therapy on Childhood Pulmonary Arterial Hypertension
2005 • 250 citations
Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis
2007 • 249 citations
Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension
2009 • 247 citations
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study
2007 • 244 citations
Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent
1999 • 241 citations
CONTINUOUS INTRAVENOUS INFUSION OF EPOPROSTENOL FOR THE TREATMENT OF PORTOPULMONARY HYPERTENSION1
1997 • 241 citations
Polymorphism of the Serotonin Transporter Gene and Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
2003 • 233 citations
Anxiety and Depression in Patients With Pulmonary Hypertension
2004 • 225 citations
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
2005 • 223 citations
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension
2005 • 220 citations
Pulmonary Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension
2006 • 217 citations
Factors that influence the outcome of primary pulmonary hypertension.
1986 • 217 citations
Prostacyclin Therapy Before Pulmonary Thromboendarterectomy in Patients With Chronic Thromboembolic Pulmonary Hypertension*
2003 • 215 citations
Nocturnal Oxygen Therapy in Patients with the Eisenmenger Syndrome
2001 • 215 citations
Pulmonary Veno-occlusive Disease
2000 • 215 citations
Sildenafil treatment for portopulmonary hypertension
2006 • 212 citations
Estimating pulmonary artery pressures by echocardiography in patients with emphysema
2007 • 212 citations
Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
2007 • 211 citations
Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension
1998 • 211 citations
Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension
2009 • 211 citations
Eisenmenger Syndrome
2009 • 206 citations
Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids
2003 • 206 citations
Short- and Long-Term Effects of Inhaled Iloprost Therapy in Children With Pulmonary Arterial Hypertension
2008 • 203 citations
Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension
2005 • 202 citations
PATHOBIOLOGY OF PULMONARY HYPERTENSION
2001 • 200 citations
Efficacy of Long-term Subcutaneous Treprostinil Sodium Therapy in Pulmonary Hypertension
2006 • 200 citations
Bosentan therapy for portopulmonary hypertension
2005 • 200 citations
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension
2006 • 197 citations
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome
2008 • 194 citations
Pulmonary Hypertension Associated with Left-Sided Heart Disease
2007 • 193 citations
Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells
2004 • 191 citations
Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
2008 • 187 citations
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
2007 • 183 citations
High Prevalence of Autoimmune Thyroid Disease in Pulmonary Arterial Hypertension
2002 • 182 citations
Pulmonary Edema Complicating Continuous Intravenous Prostacyclin in Pulmonary Capillary Hemangiomatosis
1998 • 181 citations
Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension
2007 • 181 citations
Pulmonary Arterial Thrombosis in Eisenmenger Syndrome Is Associated With Biventricular Dysfunction and Decreased Pulmonary Flow Velocity
2007 • 178 citations
Pregnancy and contraception in heart disease and pulmonary arterial hypertension
2006 • 171 citations
Outcome after Cardiopulmonary Resuscitation in Patients with Pulmonary Arterial Hypertension
2002 • 167 citations
Antinuclear antibodies in primary pulmonary hypertension
1986 • 163 citations
Atrial Septostomy in Treatment of End-Stage Right Heart Failure in Patients With Pulmonary Hypertension
2007 • 161 citations
Heart–lung or lung transplantation for Eisenmenger syndrome
2002 • 161 citations
Hypoxic Pulmonary Vasoconstriction and Gas Exchange During Exercise in Chronic Obstructive Pulmonary Disease
1990 • 161 citations
The remarkable right ventricle of patients with Eisenmenger syndrome
2005 • 158 citations
Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension
2005 • 155 citations
Prostanoids for Pulmonary Arterial Hypertension
2003 • 152 citations
Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension
2004 • 152 citations
Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension
2005 • 152 citations
N-Terminal Pro-B-Type Natriuretic Peptide as an Indicator of Disease Severity in a Heterogeneous Group of Patients With Chronic Precapillary Pulmonary Hypertension
2006 • 151 citations
Pulmonary Veno-occlusive Disease Caused by an Inherited Mutation in Bone Morphogenetic Protein Receptor II
2003 • 149 citations
Chronic thromboembolic pulmonary hypertension: Evaluation with 64-detector row CT versus digital substraction angiography
2008 • 148 citations
Intravenous Epoprostenol in Inoperable Chronic Thromboembolic Pulmonary Hypertension
2007 • 144 citations
Occult alveolar haemorrhage in pulmonary veno-occlusive disease
2005 • 142 citations
Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension
2008 • 139 citations
Sildenafil treatment in COPD does not affect stroke volume or exercise capacity
2007 • 137 citations
Hyperuricemia in Severe Pulmonary Hypertension
2000 • 137 citations
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
2006 • 137 citations
Pulmonary arterial hypertension in children
2004 • 136 citations
Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension
2005 • 136 citations
Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
1995 • 128 citations
Immediate and Long-term Hemodynamic and Clinical Effects of Sildenafil in Patients With Pulmonary Arterial Hypertension Receiving Vasodilator Therapy
2003 • 125 citations
Role of pharmacologic tests in the treatment of primary pulmonary hypertension
1995 • 124 citations
Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
2007 • 124 citations
Prognostic Implications of Serial Assessments of Pulmonary Hypertension in Severe Chronic Heart Failure
2006 • 121 citations
Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension
2008 • 120 citations
A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease
2006 • 120 citations
Epoprostenol treatment in children with severe pulmonary hypertension
2006 • 117 citations
Pharmacokinetic Interaction Between Tadalafil and Bosentan in Healthy Male Subjects
2008 • 117 citations
Indications for and Outcomes After Combined Lung and Liver Transplantation: A Single-Center Experience on 13 Consecutive Cases
2008 • 117 citations
Hepatopulmonary syndrome and portopulmonary hypertension
2003 • 114 citations
Plasma coagulation profiles in patients with severe primary pulmonary hypertension
1998 • 112 citations
Pregnancy Outcome in Patients With Pulmonary Arterial Hypertension Receiving Prostacyclin Therapy
2005 • 107 citations
Sitaxsentan for the Treatment of Pulmonary Arterial Hypertension
2008 • 106 citations
Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease
2007 • 100 citations
Pulmonary Veno-occlusive Disease*
2000 • 90 citations
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension
2007 • 89 citations
Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
2005 • 88 citations
Sildenafil improves hemodynamic parameters in COPD—an investigation of six patients
2005 • 88 citations
Mild vs Severe Pulmonary Hypertension Before Heart Transplantation: Different Effects on Posttransplantation Pulmonary Hypertension and Mortality
2005 • 85 citations
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
2008 • 85 citations
Características clínicas dos pacientes com hipertensão pulmonar em dois centros de referência em São Paulo
2006 • 83 citations
Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study
2007 • 79 citations
Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
1994 • 78 citations
New approaches for persistent pulmonary hypertension of newborn
2004 • 78 citations
Inhaled iloprost is a potent acute pulmonary vasodilator in HIV‐related severe pulmonary hypertension
2004 • 77 citations
Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses
2006 • 77 citations
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension
2008 • 70 citations
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
2008 • 67 citations
Importance of Angiotensin-Converting Enzyme in Pulmonary Hypertension
1995 • 66 citations
Long-term treatment of chronic obstructive lung disease by Nifedipine: an 18-month haemodynamic study
1988 • 60 citations
Long-term Follow-up of a Fenestrated Amplatzer Atrial Septal Occluder in Pulmonary Arterial Hypertension
2008 • 49 citations
Mechanisms of improved arterial oxygenation after peripheral chemoreceptor stimulation during hypoxic exercise
1993 • 47 citations
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension
2008 • 47 citations
Tratamiento de la hipertensión pulmonar asociada a la infección por VIH con treprostinil
2003 • 46 citations
Effects Of Sildenafil Treatment In Patients With Pulmonary Hypertension Associated With Congenital Cardiac Shunts
2010 • 9 citations
Long-term effect of bosentan in paediatric versus adult patients with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt : does the beneficial effect persist?
2007 • 8 citations
Tratamiento de la hipertensión pulmonar asociada a la infección por VIH con treprostinil
2003 • 6 citations